About the Liver Cancer Session
Liver cancer, especially hepatocellular carcinoma (HCC), poses a significant health challenge worldwide. Recent strides in cancer research are revolutionizing its diagnosis and treatment. Advances in genomic profiling are uncovering critical molecular mechanisms, paving the way for tailored therapies. Immunotherapy, particularly with immune checkpoint inhibitors, is showing encouraging results by boosting the body's immune response against cancer cells. Additionally, innovative imaging techniques are enhancing the early detection and monitoring of liver tumors. Researchers are also investigating combination therapies that merge traditional methods like surgery and chemotherapy with new treatments to achieve better outcomes. Ongoing research is vital to fully understand liver cancer and develop more effective, targeted therapies.
Topics Covered in Liver Cancer
Hepatocellular Carcinoma
Fibrolamellar Carcinoma
Hepatoblastoma
Hepatic Resection
Intra-Arterial Therapies
Checkpoint Inhibitors
Related Scientific Sessions at CIOC 2027
Why Attend the Liver Cancer Conference 2027
Earn CPD Credit
Sessions are CPD-accredited; certificates issued to every registered delegate within two weeks of the conference.
Present Your Research
Oral and poster slots for original Liver Cancer work, reviewed by the scientific committee.
Network Globally
Meet oncologists, cancer researchers, and clinical specialists from around the world across three days.
Publish & Get Indexed
Accepted abstracts appear in the indexed conference proceedings with a citable DOI.
Learn from Keynotes
Plenary lectures from leading voices shaping Liver Cancer research and practice.
Hybrid Flexibility
Attend in person in Singapore or join virtually — same programme, same certificate.
Join CIOC 2027 for the Liver Cancer track
Oral and poster slots for your work — in person in Singapore or online. Not presenting? Attend as a delegate to learn from the field.
Liver Cancer Conference 2027 — FAQs
What is the Liver Cancer track at CIOC 2027?
The Liver Cancer track is a dedicated stream within CIOC 2027 covering the latest research, clinical innovation, and best practice in Liver Cancer. It brings together researchers, educators, and practitioners for oral presentations, posters, and discussion.
Who should attend the Liver Cancer sessions?
Cancer researchers and clinicians, educators and students with an interest in Liver Cancer are all welcome — whether presenting or attending.
Can I present my research in the Liver Cancer track?
Yes. Submit an abstract for oral or poster presentation. All submissions are peer-reviewed by the scientific committee; accepted abstracts appear in the indexed proceedings.
Is virtual attendance available for Liver Cancer sessions?
Yes. CIOC 2027 is a hybrid conference — attend the Liver Cancer track in person in Singapore or join live online, with on-demand access afterward.
Join the CIOC 2027 delegation
Singapore · March 15–17, 2027· Hybrid · in-person & virtual
Attend without presenting.